Liabilities and Equity in USD of Cyteir Therapeutics, Inc. from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Cyteir Therapeutics, Inc. quarterly Liabilities and Equity history and change rate from Q4 2020 to Q3 2023.
  • Cyteir Therapeutics, Inc. Liabilities and Equity for the quarter ending 30 Sep 2023 was $131M, a 19% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Cyteir Therapeutics, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $131M -$30.7M -19% 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $134M -$40M -22.9% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $139M -$47M -25.3% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $153M -$42.2M -21.6% 31 Dec 2022 10-Q 06 Nov 2023
Q3 2022 $162M -$44.4M -21.5% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $174M -$27.7M -13.7% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $186M 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $195M +$182M +1323% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $206M 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $202M 30 Jun 2021 10-Q 09 Aug 2021
Q4 2020 $13.7M 31 Dec 2020 10-K 16 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.